Global Drugs for Oncology Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 20-May-2020
No. of pages: 158

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Drugs for Oncology will have significant change from previous year. By the most conservative estimates of global Drugs for Oncology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Drugs for Oncology market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Oncology market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Drugs for Oncology, covering the supply chain analysis, impact assessment to the Drugs for Oncology market size growth rate in several scenarios, and the measures to be undertaken by Drugs for Oncology companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Chemotherapy

- Targeted Therapy

- Immunotherapy (Biologic Therapy)

- Hormonal Therapy

- Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Roche

- Eli Lilly

- Celgene

- Bristol-Myers Squibb

- Johnson & Johnson

- Novartis

- Pfizer

- Merck & Co.

- Amgen

- AstraZeneca

- Bayer

- Teva

- Biogen Idec

- AbbVie

- Ipsen

- Astellas

- Eisai

- Sanofi

- Takeda

- Otsuka

- Gilead Sciences

- Merck KGaA

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Drugs for Oncology market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Drugs for Oncology market by identifying its various subsegments.

- Focuses on the key global Drugs for Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Drugs for Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Drugs for Oncology submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Drugs for Oncology Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Drugs for Oncology
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drugs for Oncology Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Oncology Market Size 2015-2025
2.1.2 Drugs for Oncology Market Size CAGR by Region
2.2 Drugs for Oncology Segment by Type
2.2.1 Chemotherapy
2.2.2 Chemotherapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Drugs for Oncology Market Size by Type
2.3.1 Global Drugs for Oncology Market Size Market Share by Type (2015-2020)
2.3.2 Global Drugs for Oncology Market Size Growth Rate by Type (2015-2020)
2.4 Drugs for Oncology Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Others
2.5 Drugs for Oncology Market Size by Application
2.5.1 Global Drugs for Oncology Market Size Market Share by Application (2015-2020)
2.5.2 Global Drugs for Oncology Market Size Growth Rate by Application (2015-2020)

3 Global Drugs for Oncology by Players
3.1 Global Drugs for Oncology Market Size Market Share by Players
3.1.1 Global Drugs for Oncology Market Size by Players (2018-2020)
3.1.2 Global Drugs for Oncology Market Size Market Share by Players (2018-2020)
3.2 Global Drugs for Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Drugs for Oncology by Regions
4.1 Drugs for Oncology Market Size by Regions
4.2 Americas Drugs for Oncology Market Size Growth
4.3 APAC Drugs for Oncology Market Size Growth
4.4 Europe Drugs for Oncology Market Size Growth
4.5 Middle East & Africa Drugs for Oncology Market Size Growth

5 Americas
5.1 Americas Drugs for Oncology Market Size by Countries
5.2 Americas Drugs for Oncology Market Size by Type
5.3 Americas Drugs for Oncology Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Drugs for Oncology Market Size by Regions
6.2 APAC Drugs for Oncology Market Size by Type
6.3 APAC Drugs for Oncology Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Drugs for Oncology by Countries
7.2 Europe Drugs for Oncology Market Size by Type
7.3 Europe Drugs for Oncology Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Drugs for Oncology by Countries
8.2 Middle East & Africa Drugs for Oncology Market Size by Type
8.3 Middle East & Africa Drugs for Oncology Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Drugs for Oncology Market Forecast
10.1 Global Drugs for Oncology Market Size Forecast (2021-2025)
10.2 Global Drugs for Oncology Forecast by Regions
10.2.1 Global Drugs for Oncology Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Drugs for Oncology Forecast by Type
10.8 Global Drugs for Oncology Forecast by Application

11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Drugs for Oncology Product Offered
11.1.3 Roche Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 Eli Lilly
11.2.1 Company Details
11.2.2 Drugs for Oncology Product Offered
11.2.3 Eli Lilly Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Eli Lilly News
11.3 Celgene
11.3.1 Company Details
11.3.2 Drugs for Oncology Product Offered
11.3.3 Celgene Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Celgene News
11.4 Bristol-Myers Squibb
11.4.1 Company Details
11.4.2 Drugs for Oncology Product Offered
11.4.3 Bristol-Myers Squibb Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bristol-Myers Squibb News
11.5 Johnson & Johnson
11.5.1 Company Details
11.5.2 Drugs for Oncology Product Offered
11.5.3 Johnson & Johnson Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson News
11.6 Novartis
11.6.1 Company Details
11.6.2 Drugs for Oncology Product Offered
11.6.3 Novartis Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Novartis News
11.7 Pfizer
11.7.1 Company Details
11.7.2 Drugs for Oncology Product Offered
11.7.3 Pfizer Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Pfizer News
11.8 Merck & Co.
11.8.1 Company Details
11.8.2 Drugs for Oncology Product Offered
11.8.3 Merck & Co. Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Merck & Co. News
11.9 Amgen
11.9.1 Company Details
11.9.2 Drugs for Oncology Product Offered
11.9.3 Amgen Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Amgen News
11.10 AstraZeneca
11.10.1 Company Details
11.10.2 Drugs for Oncology Product Offered
11.10.3 AstraZeneca Drugs for Oncology Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 AstraZeneca News
11.11 Bayer
11.12 Teva
11.13 Biogen Idec
11.14 AbbVie
11.15 Ipsen
11.16 Astellas
11.17 Eisai
11.18 Sanofi
11.19 Takeda
11.20 Otsuka
11.21 Gilead Sciences
11.22 Merck KGaA

12 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drugs for Oncology Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Drugs for Oncology Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Drugs for Oncology Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Targeted Therapy
Table 8. Major Players of Immunotherapy (Biologic Therapy)
Table 9. Major Players of Hormonal Therapy
Table 10. Major Players of Others
Table 11. Drugs for Oncology Market Size by Type (2014-2019) ($ Millions)
Table 12. Global Drugs for Oncology Market Size Market Share by Type (2015-2020)
Table 13. Global Drugs for Oncology Market Size by Application (2015-2020) ($ Millions)
Table 14. Global Drugs for Oncology Market Size Market Share by Application (2015-2020)
Table 15. Global Drugs for Oncology Revenue by Players (2018-2020) ($ Millions)
Table 16. Global Drugs for Oncology Revenue Market Share by Players (2018-2020)
Table 17. Global Drugs for Oncology Key Players Head office and Products Offered
Table 18. Drugs for Oncology Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Drugs for Oncology Market Size by Regions 2015-2020 ($ Millions)
Table 22. Global Drugs for Oncology Market Size Market Share by Regions 2015-2020
Table 23. Americas Drugs for Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 24. Americas Drugs for Oncology Market Size Market Share by Countries (2015-2020)
Table 25. Americas Drugs for Oncology Market Size by Type (2015-2020) ($ Millions)
Table 26. Americas Drugs for Oncology Market Size Market Share by Type (2015-2020)
Table 27. Americas Drugs for Oncology Market Size by Application (2015-2020) ($ Millions)
Table 28. Americas Drugs for Oncology Market Size Market Share by Application (2015-2020)
Table 29. APAC Drugs for Oncology Market Size by Regions (2015-2020) ($ Millions)
Table 30. APAC Drugs for Oncology Market Size Market Share by Regions (2015-2020)
Table 31. APAC Drugs for Oncology Market Size by Type (2015-2020) ($ Millions)
Table 32. APAC Drugs for Oncology Market Size Market Share by Type (2015-2020)
Table 33. APAC Drugs for Oncology Market Size by Application (2015-2020) ($ Millions)
Table 34. APAC Drugs for Oncology Market Size Market Share by Application (2015-2020)
Table 35. Europe Drugs for Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 36. Europe Drugs for Oncology Market Size Market Share by Countries (2015-2020)
Table 37. Europe Drugs for Oncology Market Size by Type (2015-2020) ($ Millions)
Table 38. Europe Drugs for Oncology Market Size Market Share by Type (2015-2020)
Table 39. Europe Drugs for Oncology Market Size by Application (2015-2020) ($ Millions)
Table 40. Europe Drugs for Oncology Market Size Market Share by Application (2015-2020)
Table 41. Middle East & Africa Drugs for Oncology Market Size by Countries (2015-2020) ($ Millions)
Table 42. Middle East & Africa Drugs for Oncology Market Size Market Share by Countries (2015-2020)
Table 43. Middle East & Africa Drugs for Oncology Market Size by Type (2015-2020) ($ Millions)
Table 44. Middle East & Africa Drugs for Oncology Market Size Market Share by Type (2015-2020)
Table 45. Middle East & Africa Drugs for Oncology Market Size by Application (2015-2020) ($ Millions)
Table 46. Middle East & Africa Drugs for Oncology Market Size Market Share by Application (2015-2020)
Table 47. Key and Potential Regions of Drugs for Oncology
Table 48. Key Application and Potential Industries of Drugs for Oncology
Table 49. Key Challenges of Drugs for Oncology
Table 50. Key Trends of Drugs for Oncology
Table 51. Global Drugs for Oncology Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 52. Global Drugs for Oncology Market Size Market Share Forecast by Regions
Table 53. Global Drugs for Oncology Market Size Forecast by Type (2021-2025) ($ Millions)
Table 54. Global Drugs for Oncology Market Size Market Share Forecast by Type (2021-2025)
Table 55. Global Drugs for Oncology Market Size Forecast by Application (2021-2025) ($ Millions)
Table 56. Global Drugs for Oncology Market Size Market Share Forecast by Application (2021-2025)
Table 57. Roche Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 58. Roche Drugs for Oncology Product Offered
Table 59. Roche Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 60. Roche Main Business
Table 61. Roche Latest Developments
Table 62. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 63. Eli Lilly Drugs for Oncology Product Offered
Table 64. Eli Lilly Main Business
Table 65. Eli Lilly Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 66. Eli Lilly Latest Developments
Table 67. Celgene Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 68. Celgene Drugs for Oncology Product Offered
Table 69. Celgene Main Business
Table 70. Celgene Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 71. Celgene Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 73. Bristol-Myers Squibb Drugs for Oncology Product Offered
Table 74. Bristol-Myers Squibb Main Business
Table 75. Bristol-Myers Squibb Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 78. Johnson & Johnson Drugs for Oncology Product Offered
Table 79. Johnson & Johnson Main Business
Table 80. Johnson & Johnson Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 81. Johnson & Johnson Latest Developments
Table 82. Novartis Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 83. Novartis Drugs for Oncology Product Offered
Table 84. Novartis Main Business
Table 85. Novartis Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 86. Novartis Latest Developments
Table 87. Pfizer Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 88. Pfizer Drugs for Oncology Product Offered
Table 89. Pfizer Main Business
Table 90. Pfizer Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 91. Pfizer Latest Developments
Table 92. Merck & Co. Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 93. Merck & Co. Drugs for Oncology Product Offered
Table 94. Merck & Co. Main Business
Table 95. Merck & Co. Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 96. Merck & Co. Latest Developments
Table 97. Amgen Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 98. Amgen Drugs for Oncology Product Offered
Table 99. Amgen Main Business
Table 100. Amgen Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 101. Amgen Latest Developments
Table 102. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 103. AstraZeneca Drugs for Oncology Product Offered
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Drugs for Oncology Revenue and Gross Margin (2018-2020E)
Table 106. AstraZeneca Latest Developments
Table 107. Bayer Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 108. Teva Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 109. Biogen Idec Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 110. AbbVie Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 111. Ipsen Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 112. Astellas Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 113. Eisai Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 114. Sanofi Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 115. Takeda Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 116. Otsuka Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 117. Gilead Sciences Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors
Table 118. Merck KGaA Details, Company Total Revenue (in $ million), Head Office, Drugs for Oncology Major Market Areas and Its Competitors

List of Figures

Figure 1. Drugs for Oncology Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Drugs for Oncology Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Drugs for Oncology Market Size Market Share by Type (2015-2020)
Figure 5. Global Chemotherapy Market Size Growth Rate
Figure 6. Global Targeted Therapy Market Size Growth Rate
Figure 7. Global Immunotherapy (Biologic Therapy) Market Size Growth Rate
Figure 8. Global Hormonal Therapy Market Size Growth Rate
Figure 9. Global Others Market Size Growth Rate
Figure 10. Drugs for Oncology in Blood Cancer
Figure 11. Global Drugs for Oncology Market: Blood Cancer (2015-2020) ($ Millions)
Figure 12. Drugs for Oncology in Breast Cancer
Figure 13. Global Drugs for Oncology Market: Breast Cancer (2015-2020) ($ Millions)
Figure 14. Drugs for Oncology in Gastrointestinal Cancer
Figure 15. Global Drugs for Oncology Market: Gastrointestinal Cancer (2015-2020) ($ Millions)
Figure 16. Global Gastrointestinal Cancer YoY Growth ($ Millions)
Figure 17. Drugs for Oncology in Prostate Cancer
Figure 18. Global Drugs for Oncology Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 19. Global Prostate Cancer YoY Growth ($ Millions)
Figure 20. Drugs for Oncology in Respiratory/Lung Cancer
Figure 21. Global Drugs for Oncology Market: Respiratory/Lung Cancer (2015-2020) ($ Millions)
Figure 22. Global Respiratory/Lung Cancer YoY Growth ($ Millions)
Figure 23. Global Drugs for Oncology Market Size Market Share by Application in 2019
Figure 24. Global Drugs for Oncology Market Size Market Share by Regions 2015-2020
Figure 25. Americas Drugs for Oncology Market Size 2015-2020 ($ Millions)
Figure 26. APAC Drugs for Oncology Market Size 2015-2020 ($ Millions)
Figure 27. Europe Drugs for Oncology Market Size 2015-2020 ($ Millions)
Figure 28. Middle East & Africa Drugs for Oncology Market Size 2015-2020 ($ Millions)
Figure 29. Americas Drugs for Oncology Market Size Market Share by Countries in 2019
Figure 30. Americas Drugs for Oncology Market Size Market Share by Type in 2019
Figure 31. Americas Drugs for Oncology Market Size Market Share by Application in 2019
Figure 32. United States Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 33. Canada Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 34. Mexico Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 35. APAC Drugs for Oncology Market Size Market Share by Regions in 2019
Figure 36. APAC Drugs for Oncology Market Size Market Share by Type in 2019
Figure 37. APAC Drugs for Oncology Market Size Market Share by Application in 2019
Figure 38. China Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 39. Japan Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 40. Korea Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 41. Southeast Asia Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 42. India Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 43. Australia Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 44. Europe Drugs for Oncology Market Size Market Share by Countries in 2019
Figure 45. Europe Drugs for Oncology Market Size Market Share by Type in 2019
Figure 46. Europe Drugs for Oncology Market Size Market Share by Application in 2019
Figure 47. Germany Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 48. France Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 49. UK Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 50. Italy Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 51. Russia Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 52. Spain Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 53. Middle East & Africa Drugs for Oncology Market Size Market Share by Countries in 2019
Figure 54. Middle East & Africa Drugs for Oncology Market Size Market Share by Type in 2019
Figure 55. Middle East & Africa Drugs for Oncology Market Size Market Share by Application in 2019
Figure 56. Egypt Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 57. South Africa Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 58. Israel Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 59. Turkey Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 60. GCC Countries Drugs for Oncology Market Size Growth 2015-2020 ($ Millions)
Figure 61. Global Drugs for Oncology arket Size Forecast (2021-2025) ($ Millions)
Figure 62. Americas Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 63. APAC Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 64. Europe Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 65. Middle East & Africa Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 66. United States Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 67. Canada Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 68. Mexico Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 69. Brazil Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 70. China Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 71. Japan Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 72. Korea Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 73. Southeast Asia Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 74. India Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 75. Australia Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 76. Germany Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 77. France Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 78. UK Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 79. Italy Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 80. Russia Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 81. Spain Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 82. Egypt Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 83. South Africa Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 84. Israel Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 85. Turkey Drugs for Oncology Market Size 2021-2025 ($ Millions)
Figure 86. GCC Countries Drugs for Oncology Market Size 2021-2025 ($ Millions)
  • Global Uric Acid Drug Market Growth 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 130
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Advanced Therapy Medicinal Products Market Growth, Trends, and Forecasts 2015-2025
    Published: 03-Jun-2020        Price: US 5660 Onwards        Pages: 113
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Neuromyelitis Optic Spectrum Disorder Drugs Market Growth 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 159
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Drugs for Neuromyelitis Optica Market Growth 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 164
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Sphingosine-1-Receptor Modulators Drugs Market Growth 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 135
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Farm Animals Medicines and Vaccines Market Growth (Status and Outlook) 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 136
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Veterinary Medicines and Vaccines Market Growth (Status and Outlook) 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 134
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Companion Animals Medicines and Vaccines Market Growth (Status and Outlook) 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 139
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Ketogenic Diet Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 03-Jun-2020        Price: US 3660 Onwards        Pages: 139
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs